03.11.19
Food and Drug Administration (FDA) Commissioner Scott Gottlieb said he will resign next month, creating some uncertainty about how the agency will move forward with regulatory initiatives in the dietary supplement industry.
In February, Gottlieb announced FDA will embark on a plan to implement “one of the most significant modernizations of dietary supplement regulation and oversight in more than 25 years,” with a public meeting to be scheduled in May on possible amendments to the Dietary Supplement Health and Education Act (DSHEA). At the same time the agency sent about a dozen warning letters to companies selling illegal, unapproved new drugs marketed as dietary supplements.
FDA also recently announced it will hold a public meeting in April about a legal regulatory path for cannabidiol (CBD), which the agency has to date considered illegal in dietary supplements and food because it was the subject of substantial clinical investigations before it was
FREE SUBSCRIPTION
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
